fbpx

“The solution offered by Aiforia for AI in pathology is extremely user-friendly and while it relies heavily on correct annotation by disease specialists, it assumes very little prior knowledge of AI – a perfect combination for me. “

What do you do and what is your research focus?

I am a thoracic pathologist and my research interests include both neoplastic and non-neoplastic diseases of the thorax, including lung cancer, mesothelioma, thymoma, interstitial lung disease and lung and heart transplantation.

Why did you apply to the aiForward program?

The solution offered by Aiforia for AI in pathology is extremely user-friendly and while it relies heavily on correct annotation by disease specialists, it assumes very little prior knowledge of AI – a perfect combination for me. Also, the online support offered by knowledgeable Aiforia staff is extremely helpful, including very useful instruction videos.

Had you thought much about using AI in your research before applying to aiForward?

No, while we had been considering entering the field for a while, participating in an AiForward program has really kick-started our AI research.

Tell us a little bit about your aiForward project.

Classification of rejection in solid organ transplantation is subject to interobserver variation. In an effort to reduce the variability and to improve correlation with outcome, as well as a point to potentially useful subclassifications of current categories, we have started an aiForward program to score kidney and heart biopsies according to current guidelines.

What are your expectations for the program?

To develop an algorithm which reproduces current transplant rejection scoring systems, as well as (hopefully) provides a more accurate correlation with clinical outcome.

Applications to the aiForward program are accepted on a continuous basis.

Apply Now